For 2017–2018, there are 14 primary care NPIs focusing on seven areas of prescribing and the reporting of adverse events (Yellow Cards). Four of the indicators – high strength inhaled corticosteroids (ICS), opioid patches, anticholinergic burden, and NSAIDs and CKD – are new for 2017–2018.
There are also three secondary care NPIs focusing on three areas of prescribing.
On a quarterly basis, a report is compiled analysing the performance of each health board against the current set of NPIs.
⇩ National Prescribing Indicators 2017–2018: Analysis of Prescribing Data to March 2018 3,743KB (PDF) |
⇩ National Prescribing Indicators 2017–2018: Analysis of Prescribing Data to December 2017 3,127KB (PDF) |
⇩ National Prescribing Indicators 2017–2018: Analysis of Prescribing Data to September 2017 2,917KB (PDF) |
⇩ National Prescribing Indicators 2017–2018: Analysis of Prescribing Data to June 2017 2,655KB (PDF) |